Experts see improvements with bypass liner in diabetes

02/1/2013 | Medscape (free registration)

Moderately obese type 2 diabetes patients who used a duodenal-jejunal bypass liner attained significant reductions in fasting plasma glucose and A1C levels and body weight at 52 weeks, a study in the Journal of Clinical Endocrinology and Metabolism indicated. Researchers also noted lower bad cholesterol and triglyceride rates in patients.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY